Courtney Breen
Stock Analyst at Bernstein
(0.32)
# 4,337
Out of 5,165 analysts
4
Total ratings
n/a
Success rate
-7.35%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Courtney Breen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Downgrades: Market Perform | $335 | $361.13 | -7.24% | 1 | Jan 20, 2026 | |
| LLY Eli Lilly and Company | Maintains: Outperform | $1,100 → $1,300 | $930.35 | +39.73% | 1 | Nov 24, 2025 | |
| MRNA Moderna | Initiates: Market Perform | $55 | $53.93 | +1.98% | 1 | Oct 17, 2024 | |
| PFE Pfizer | Initiates: Market Perform | $32 | $27.45 | +16.58% | 1 | Oct 17, 2024 |
Amgen
Jan 20, 2026
Downgrades: Market Perform
Price Target: $335
Current: $361.13
Upside: -7.24%
Eli Lilly and Company
Nov 24, 2025
Maintains: Outperform
Price Target: $1,100 → $1,300
Current: $930.35
Upside: +39.73%
Moderna
Oct 17, 2024
Initiates: Market Perform
Price Target: $55
Current: $53.93
Upside: +1.98%
Pfizer
Oct 17, 2024
Initiates: Market Perform
Price Target: $32
Current: $27.45
Upside: +16.58%